Sodium Benzoate: Clinical Trials

4 trials of Sodium Benzoate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 1, Withdrawn 1

Follow Sodium Benzoate: new trials by email Literature Review of Sodium Benzoate trials Research Report on Sodium Benzoate

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.
Sodium Benzoate, N-Acetylcysteine, Placebo - Schizophrenia, Schizophreniform Disorders
Phase 2CompletedPakistan Institute of Living and Learning642019-01-012022-04-27
Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.
Sodium Benzoate, Placebo - Attenuated or Transient Psychosis
Phase 2WithdrawnNiuvanniemi Hospital2014-02-012014-04-10
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
sodium phenylacetate and sodium benzoate injection 10% / 10%, placebo solution (10% dextrose) - Hepatic Encephalopathy
Phase 2TerminatedAmgen12007-12-012024-12-17
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Sodium Benzoate, Sodium Phenylacetate, Sodium Phenylbutyrate - Amino Acid Metabolism, Inborn Errors
Phase 2CompletedNational Center for Research Resources (NCRR)201985-01-012005-06-24

Conditions studied

Amino Acid Metabolism, Inborn Errors (1)  ·  Hepatic Encephalopathy (1)  ·  Inflammation (1)  ·  Lymphoma, Follicular (1)  ·  Metabolism, Inborn Errors (1)  ·  Psychotic Disorders (1)  ·  Rare Diseases (1)  ·  Schizophrenia (1)  ·  Urea Cycle Disorders, Inborn (1)

Sponsors

Amgen (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Niuvanniemi Hospital (1)  ·  Pakistan Institute of Living and Learning (1)

Countries

Finland (1)  ·  Pakistan (1)  ·  United States (1)

Top investigators

Imran B Chaudhry, MD (1)  ·  Jari Tiihonen, MD, PhD (1)  ·  Saul W. Brusilow (1)

Results publications

PMID 39144112